Strobel, Katie M. http://orcid.org/0000-0002-7717-0425
Wood, Thomas R. http://orcid.org/0000-0002-1130-2720
Valentine, Gregory C. http://orcid.org/0000-0002-3055-2987
German, Kendell R.
Gogcu, Semsa http://orcid.org/0000-0002-0429-9404
Hendrixson, D. Taylor http://orcid.org/0000-0003-0627-3571
Kolnik, Sarah E. http://orcid.org/0000-0003-1397-8430
Law, Janessa B.
Mayock, Dennis E. http://orcid.org/0000-0002-6190-4842
Comstock, Bryan A.
Heagerty, Patrick J.
Juul, Sandra E. http://orcid.org/0000-0002-6861-6229
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (U01NS077953, U01NS077955)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
Article History
Received: 2 August 2023
Revised: 1 December 2023
Accepted: 5 December 2023
First Online: 9 January 2024
Competing interests
: The authors declare no competing interests.
: The PENUT Trial was approved by the institutional review board at each participating site and was registered with the Food and Drug Administration. Each participant participated with informed consent. The study was performed in accordance with Declaration of Helsinki.